Anti-obesity Drugs Market is expanding rapidly with Novo Nordisk announced the Phase IIIa obesity trial for an oral formulation

 

Obesity Management Drugs Market

Weight loss drugs or anti-obesity drugs are pharmacological substances that regulate weight or reduce it. These drugs change one of the most fundamental processes of our body, weight regulation, through altering either absorption appetite or activity of calories in the body. One of the most obvious reasons for the high adoption of anti-obesity drugs is rising burden of obesity and relevant chronic diseases. As per the World Health Organization (WHO), in 2016, over 1.9 billion adults aged 18 years and above were overweight, of which around 650 million were obese. As per the same source, in 2016, around 340 million children and adolescents aged 5-19 years were overweight or obese. Such high incidence of obesity has necessitated the adoption of effective drugs. Hence, such factors can stimulate the growth of the anti-obesity drugs market.

Lifestyle and eating habits across the globe have changed becoming increasingly unhealthy. Such unhealthy cousin habits are leading to the emergence of many lifestyle-related diseases such as hypertension, diabetes, obesity, and stress. Thus, such factors could potentially augment growth of the anti-obesity drugs market. Recently, in April 2021, Novo Nordisk announced the Phase IIIa obesity trial for an oral formulation. 

The most common and highly prescribed anti-obesity drug is Aciphexane or AMP. It has been found to be very effective at suppressing the appetite and keeping one physically alert. Its main component, chlorogenic acid, stimulates thermogenesis, a process by which the body produces heat. Research studies have shown that Aciphexane also regulates nutrient absorption in the intestines, a factor that can also contribute to obesity. As far as regional impact is concerned, North America seems to be gaining significant traction in the anti-obesity drugs market. This is typically due to the high incidence of obesity and overweight cases in the U.S. On the contrary, Asia Pacific is likely to register promising signs with rising awareness regarding the risk associated with obesity among the populace.

Most of these drugs have a central mechanism that involves dopamine, an important neurotransmitter in the brain and other areas. In fact, dopamine is believed to be responsible for feelings of pleasure, motivation, and energy. Regardless of how effective these drugs are, certain issues can be major hurdles in the development of the market. Since there is the availability of alternative treatment options, the adoption of the anti-obesity drugs market is likely to be hindered. Besides, side effects of these drugs can impede growth of the anti-obesity drugs market in the near future.


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

Botanical and Plant Derived Drugs Market by Source,Dosage - Global Industry Analysis,Size,Share

Pressure Bandages Market : Global Industry Analysis and Opportunity Assessment